Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Novel PSMA-targeting ligand PSMA-TO-1 shows prolonged circulation time and higher tumor uptake

Oct. 25, 2021

Fusion Pharmaceuticals evaluates alpha particle-emitting NTSR1 antagonist for colorectal cancer

Oct. 25, 2021

Shanghai Synergy Pharmaceutical Sciences, Zhejiang Huahai Pharmaceutical identify kinase inhibitors

Oct. 25, 2021

PKMYT1 inhibitors discovered at Repare Therapeutics

Oct. 25, 2021

Bayer and collaborators describe new EGFR inhibitors

Oct. 25, 2021

Cedilla announces lead programs focused on conditional inhibition of TEAD and CDK2

Oct. 22, 2021

Loxo Oncology details discovery and testing of PI3Kalpha and FGFR inhibitors

Oct. 22, 2021

GLI1 inhibition as a novel strategy for the treatment of uterine leiomyosarcoma

Oct. 22, 2021

Enyo Pharma presents ICD inducers

Oct. 22, 2021

Fujifilm patents HDAC6 inhibitors

Oct. 22, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2026.
CINP 2026: Prenatal and adolescent stress shape brain vulnerability
BioWorld Science
Human biology is extraordinarily complex, and that sophistication emerges from the very beginning. During embryonic and fetal development, the organism’s...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
In the clinic for July 6, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Arcus, Genentech, Merck, Myriad, Otsuka, Partner, Revolution, Treos.